| Biological Information | |
|---|---|
| Background Information: | IFN-γ (interferon-gamma) is produced by CD4 and CD8 T lymphocytes and activated NK cells, and it stimulates a number of lymphoid cell functions, including the anti-microbial and anti-tumor responses of macrophages, NK cells, and neutrophils. IFN-γ receptors (IFNGR1) are present in most immune cells, which respond to IFN-γ signaling by increasing the surface expression of class I MHC proteins. This promotes the presentation of antigen to T-helper (CD4+) cells. IFN-γ signaling in antigen-presenting cells, and antigen-recognizing B and T lymphocytes, regulates the antigen-specific phases of the immune response. Provided as 20 μg of dry powder alongside reconstitution buffer. |
| Target Name: | IFN-γ |
| Usage | |
| Product Type: | Recombinant Proteins |
| Application: | Drug Discovery & Development |
| Storage Conditions: | Store at -20°C. Please avoid multiple freeze/thaw cycles. |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Additional Information | |
| Brand: | DiscoverX |
Recombinant Human IFN-gamma
Recombinant Human IFN-gamma is an agonist for IFNGR1. This product is provided as 20μg of dry powder alongside reconstitution buffer.
Datasheets
92-1323 Datasheet
View Document